The largest database of trusted experimental protocols

Anti yap1

Manufactured by Cell Signaling Technology
Sourced in United States, China

Anti-YAP1 is a laboratory reagent that can be used to detect and study the YAP1 protein. YAP1 is a key regulator of the Hippo signaling pathway, which plays a role in cell growth, proliferation, and survival. Anti-YAP1 can be used in various research applications, such as Western blotting, immunoprecipitation, and immunohistochemistry, to investigate the expression and localization of YAP1 in biological samples.

Automatically generated - may contain errors

47 protocols using anti yap1

1

Transcriptional Regulation by HNF4A and TEAD

Check if the same lab product or an alternative is used in the 5 most similar protocols
HNF4A and HNF4A DN expression vectors were provided by T. Leff (Hong et al., 2003 (link)). TEAD2 and YAP1 expression vectors were provided by J.F. Martin (Heallen et al., 2011 (link)). TEAD DN and YAP S94A expression vectors were previously described (Shen et al., 2012 (link)). Enhancer regions were PCR amplified and cloned into a PGL3 basic vector containing the E1B minimal promoter. TK-Renilla controlled for transfection efficiency. HEK293T were maintained in Dulbecco's modified Eagle's medium containing 10% fetal bovine serum. Transfections were performed using PEI (Raju et al., 2013 (link)). Firefly and Renilla activity was measured with a Dual Luciferase Reporter Assay kit (Promega) and presented as the Firefly/Renilla ratio. Western blot analysis was carried out on nuclear extracts from pooled embryonic livers (E14.5) and female adult liver using anti-YAP1 (Cell Signaling), anti-TEF4 (Tead2; Novus Biologicals), and anti-beta actin (Santa Cruz). Nuclear extracts for EMSAs were prepared from 293T cells transfected with TEAD-myc/HNF4-myc or E14.5 as previously described (Labbé et al., 1998 (link)).
+ Open protocol
+ Expand
2

Immunohistochemical Analysis of YAP1 and NMU in Pancreatic Cancer

Check if the same lab product or an alternative is used in the 5 most similar protocols
A TMA for pancreatic cancer was purchased from US Biomax (PA721a, Rockville, MD, USA) and immunostained with anti-YAP1 (#12395, Cell Signaling) and anti-NMU (NMU41-A, Alpha Diagnostics International Inc., San Antonio, TX, USA) antibodies using a Dako REAL EnVision Detection System (Dako) following the manufacturer’s instructions. The cutoff value was defined on the basis of the method reported by Li et al. [53 (link)] with slight modifications, such as using the expression range 0–5 to divide samples according to low and high expression of YAP1 and NMU. All scores were evaluated separately; the mean calculated score was used to represent the immunoreactivity of the tumor. The correlation between YAP1 and NMU was evaluated by Pearson’s correlation, and the association between ordinal variables was assessed.
+ Open protocol
+ Expand
3

Protein Expression Analysis of PANC-1 and AsPC-1 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
PANC-1 or AsPC-1 cells were cultured in six-well plates and total protein was extracted by RIPA lysis buffer (Beyotime, China). After the cell lysates were sonicated, and treated with the BCA Protein Analysis kit (Beyotime, China) to detect the concentration of protein by using an enzyme-labeled instrument (Molecular Devices, USA). Proteins were used to SDS-page and transferred to nitrocellulose filter membrane (Pall Corporation, USA), blocked with rapid blocking buffer (GenScript, USA) for 17 min and incubated with primary antibody overnight at 4 °C. The next day it was washed with TBST and incubated with secondary antibodies for 40 min, the membranes were scanned and analyzed with Odyssey infrared imaging instrument (LI-COR, USA). Antibodies used in this study include: anti-β-actin (1:20,000, ABclonal, China), anti-YAP1 (1:1500, Cell Signaling Technology, USA), anti-CTGF (1:1000, Novus Biologicals, USA), and secondary antibody (800R rabbit antibody, 1:1000, LI-COR, USA).
+ Open protocol
+ Expand
4

Evaluation of Esophageal Adenocarcinoma Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
We used the human EAC cell lines BE3, Flo‐1, SKGT‐4, JHESO, and OACP, and radiation‐resistant EAC cell line Flo‐1 XTR that have been described previously (Raju et al., 2006; Soldes et al., 1999; Wang et al., 2012). All cell lines were authenticated at the Characterized Cell Line Core at UT MD Anderson Cancer Center regularly. JQ1 was obtained from Selleck Chemicals (St. Louis, MO, USA). Doxycycline (Dox) was from Sigma‐Aldrich. Anti‐YAP1 purchased from Cell Signaling Technology was previously described. Anti‐SOX9 and BRD4 antibodies were obtained from EMD Millipore (Massachusetts 01821). Antibodies against β‐catenin, EGFR, phosphor‐S6, phosphor‐70S6K, and c‐MYC were from Cell Signaling Technology (Boston, MA 02241‐3843). BRD4 plasmid (pcDNA2‐BRD4) and doxycycline‐inducible YAP1 lentiviral plasmid (PIN20YAP1) were previously reported (Song et al., 2017).
+ Open protocol
+ Expand
5

ChIP Analysis of ZEB1 and YAP1 in MDA-MB-231 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
MDA-MB-231 cells were cultured in 150-mm dishes as previously described (Watanabe et al., 2014 (link)). ChIP was performed as previously described (Gu et al., 2013 (link)) with modifications. Briefly, cells were cross-linked with 1% formaldehyde for 10 minutes at room temperature, followed by quenching with 0.125 M glycine for 5 minutes at room temperature. After washing, chromatin was sheared to produce ~100–500-bp fragments using Bioruptor Sonicator (Diagenode Inc.) at “high” setting with 30-second ON and 30-second OFF cycles for a total of 30 minutes. A small aliquot of the recovered supernatant underwent subsequent reverse crosslinking and DNA purification, and the resulting DNA was used to assess concentration and shearing efficiency (input sample). Twenty-five μg of the crosslinked chromatin in the remaining supernatant was immunoprecipitated by overnight incubation at 4°C with control IgG (Santa Cruz Biotechnology, sc-2027) or anti-ZEB1 (Novus Biologicals, NBPI-88845), anti-ZEB1 (Santa Cruz Biotechnology, h-102), or anti-YAP1 (Cell Signaling Technology, 8418) antibodies. Antibody-chromatin immunocomplexes were then purified as previously described (Gu et al., 2013 (link)). ChIP DNA was recovered and purified using phenol: chloroform: isoamyl alcohol purification and then used for real-time PCR using primers listed in Table S6.
+ Open protocol
+ Expand
6

Transcriptional Regulation by HNF4A and TEAD

Check if the same lab product or an alternative is used in the 5 most similar protocols
HNF4A and HNF4A DN expression vectors were provided by T. Leff (Hong et al., 2003 (link)). TEAD2 and YAP1 expression vectors were provided by J.F. Martin (Heallen et al., 2011 (link)). TEAD DN and YAP S94A expression vectors were previously described (Shen et al., 2012 (link)). Enhancer regions were PCR amplified and cloned into a PGL3 basic vector containing the E1B minimal promoter. TK-Renilla controlled for transfection efficiency. HEK293T were maintained in Dulbecco's modified Eagle's medium containing 10% fetal bovine serum. Transfections were performed using PEI (Raju et al., 2013 (link)). Firefly and Renilla activity was measured with a Dual Luciferase Reporter Assay kit (Promega) and presented as the Firefly/Renilla ratio. Western blot analysis was carried out on nuclear extracts from pooled embryonic livers (E14.5) and female adult liver using anti-YAP1 (Cell Signaling), anti-TEF4 (Tead2; Novus Biologicals), and anti-beta actin (Santa Cruz). Nuclear extracts for EMSAs were prepared from 293T cells transfected with TEAD-myc/HNF4-myc or E14.5 as previously described (Labbé et al., 1998 (link)).
+ Open protocol
+ Expand
7

Molecular Mechanisms in HepG2 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
HepG2 and HepG2/ADR cells were harvested after 48 h treatment and lysed using RIPA buffer (R0278; Sigma Aldrich, St Louis, MO, USA). The lysates were centrifuged and the supernatant was collected for Western blotting as the routine protocol. The following antibodies were used: anti-AEG-1 (1:2,000; ProteinTech, IL, USA), anti-YAP1 (1:1,000; Cell signaling, MA, USA), anti-Bcl-2 (1:1,000; Cell signaling, USA), anti-cleaved-caspase-3 (1:1,000; Cell signaling, USA), anti-caspase-3 (1:1,000; Cell signaling, USA), anti-Bax (1:1,000; Cell signaling, USA), anti-P-gp (1:1,000; Abcam, Cambridge, UK), and anti-α-tubulin (1:1,000; Promoter, Wuhan, China).
+ Open protocol
+ Expand
8

Western Blot Analysis of Stem Cell Markers

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were harvested, washed with PBS, and lysed with lysis buffer supplemented with protease inhibitors (Roche, Sainte‐Agathe‐Nord, QC, Canada). After the protein concentrations were determined using a Bio‐Rad DC protein assay kit (Bio‐Rad, Hercules, CA, USA), samples were then normalized and denatured. The samples were then loaded into an 8% polyacrylamide gel and separated by SDS/PAGE followed by transference to a PVDF membrane. Proteins were identified by incubation with primary antibodies followed by horseradish peroxidase‐conjugated secondary antibodies and an enhanced chemiluminescence solution (Thermo Scientific, Waltham, MA, USA). Antibodies used in this study include the following: anti‐YAP1(1 : 1000, Cat: 4912; Cell Signaling, Cambridge, MA, USA), anti‐CD44 (8E2) monoclonal antibody (1 : 1000, Cat: 5640; Cell Signaling), anti‐ALDH1A1 (1 : 1000, Cat: ab105920; Abcam, Toronto, ON, Canada), anti‐Klf4 (1 : 1000, Cat: ab72543; Abcam), anti‐β‐catenin (1 : 1000, Cat: 610153, Clone 14; BD, Mississauga, ON, Canada), anti‐active β‐catenin (1 : 500, Cat: 05665, Clone 8E7; Millipore, Billerica, MA, USA), and anti‐α‐tubulin monoclonal antibody (1 : 500, Cat: T9026; Sigma‐Aldrich).
+ Open protocol
+ Expand
9

ChIP Assay for YAP1 and TEAD1 Binding

Check if the same lab product or an alternative is used in the 5 most similar protocols
ChIP assay was performed according to the manufacturer’s guidance (Invitrogen MAGnify ChIP system). Briefly, sorted CD4+ iTregs were activated with αCD3/αCD28-conjugated beads overnight and fixed with 2% formaldehyde. Sonicated DNA was immunoprecipitated with anti-YAP1 (Cell Signaling Technology), and anti-TEAD1 (Santa Cruz Biotechnology). The immunoprecipitated chromatin was analyzed on Roche LightCycler 480 by SYBR Green using the following primers for AcVR1c promoter: 5′-CATTGACGTCTCTATG GAAG-3′(forward), 5′-CAAGCACCATTGCCTTCAGAC-3′(reverse).
+ Open protocol
+ Expand
10

Investigating Transcriptional Regulation Mechanisms

Check if the same lab product or an alternative is used in the 5 most similar protocols
ChIP: anti-H3K27ac (Abcam, ab4729), anti-H3K4me3 (Active Motif, #39159), anti-H3K4me1 (Abcam, ab8895), anti-H3K122Ac (Abcam ab33309), anti-MycN262 (Santa Cruz, sc-764), anti-RNAPol2 N20-X (Santa Cruz, sc-899), anti-YAP1 63.7 (Santa Cruz, sc-101199), anti-TEAD4 (Aviva Systems Biology, ARP38276), anti-BRD4 (Bethyl, A301-985A100), anti-HNF4a (Abcam, ab41898). Normal rabbit/mouse IgG (Santa Cruz, sc-2027) was used as background control. Please note that the anti-TEAD4 (Aviva Systems Biology, ARP38276) was reported to recognize also TEAD1 and TEAD3 (33 (link)). Western-Blot: anti-YAP1 63.7 (Santa Cruz, sc 101199) and anti-TEAD4 (Santa Cruz, sc-101184); anti-HNF4a (Abcam, ab199431), anti-total H3 (Abcam, ab1791); anti-vinculin clone H (SigmaAldrich, V9131); anti-TEAD1 (Cell Signalling, #8526). Goat anti-rabbit HRP (Biorad, #1706515) and Goat anti-mouse HRP (Biorad, #1706516) were used as secondary antibodies. Immunohistochemistry: anti-YAP1 (Cell Signalling, #4911), anti-Ki67 (Thermo Scientific, #9106), anti-Sox9 (Millipore, #5535), anti-HNF4a (Santa Cruz, sc-8987 and Abcam, ab41898).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!